AAAAAA
Results:
1-9
|
Results: 9
Authors:
Garcia-Paredes, J
Pena, AS
Citation: J. Garcia-paredes et As. Pena, 1st International Meeting on Chronic Inflammatory Bowel Disease - Clinicalcases, progress and basis of treatment - Madrid, May 4-5, 2000 - Preface, DRUGS TODAY, 37, 2001, pp. 1-1
Authors:
Garcia-Paredes, J
Gomollon, F
Santamaria, DMC
Abreu, L
Vera, M
Fazio, VW
Sandborn, WS
Citation: J. Garcia-paredes et al., Steroid dependency and steroid resistance in inflammatory bowel disease, DRUGS TODAY, 37, 2001, pp. 17-18
Authors:
Garcia-Paredes, J
Citation: J. Garcia-paredes, Patient case 1: A steroid-dependent patient, DRUGS TODAY, 37, 2001, pp. 19-22
Authors:
Cruz-Santamaria, DM
Velasco, M
Garcia-Paredes, J
Citation: Dm. Cruz-santamaria et al., Clinical experience with 6-mercaptopurine, DRUGS TODAY, 37, 2001, pp. 35-42
Authors:
Gonzalez-Lara, V
Lofberg, R
Armengol, JAR
Fazio, V
Irvine, EJ
Garcia-Paredes, J
Citation: V. Gonzalez-lara et al., The long-term evolution of ulcerative colitis, DRUGS TODAY, 37, 2001, pp. 89-90
Authors:
Pena, AS
Manoliu, RA
Bloemena, E
Rodriguez, A
Fuentes, A
Alvarez, A
Geijo, F
Matilla, A
Lopez-Nava, G
Garcia-Paredes, J
Citation: As. Pena et al., The importance of the patient in the management of the disease, DRUGS TODAY, 37, 2001, pp. 277-277
Authors:
Rodriguez, A
Fuentes, A
Alvarez, A
Geijo, F
Matilla, A
Lopez-Nava, G
Garcia-Paredes, J
Citation: A. Rodriguez et al., Patient case 2: Does refractory Crohn's disease exist?, DRUGS TODAY, 37, 2001, pp. 285-289
Authors:
Garcia-Paredes, J
Lopez-Nava, G
Citation: J. Garcia-paredes et G. Lopez-nava, New types of hepatobiliary lesions in inflammatory bowel disease, REV ESP E D, 92(2), 2000, pp. 65-67
Authors:
de la Concha, EG
Fernandez-Arquero, M
Martinez, A
Vigil, P
Vidal, F
Lopez-Nava, G
Diaz-Rubio, M
Garcia-Paredes, J
Citation: Eg. De La Concha et al., Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis, DIG DIS SCI, 44(11), 1999, pp. 2324-2329
Risultati:
1-9
|